Literature DB >> 3827292

Outbreak of cephalosporin resistant Enterobacter cloacae infection in a neonatal intensive care unit.

N Modi, V Damjanovic, R W Cooke.   

Abstract

Enterobacter cloacae resistant to third generation cephalosporins emerged rapidly during an outbreak of serious infections due to this organism in a neonatal intensive care unit where ampicillin and gentamicin were used as first line antibiotic treatment. Organisms resistant to cephalosporins were isolated from 12 infants, six of whom developed systemic infection. Two infants died. Isolates of E. cloacae from four of five infants treated with cefotaxime showed a loss of sensitivity to this antibiotic during treatment, but in the three infants who survived sensitive organisms were again isolated after treatment had stopped. Stopping treatment with the cephalosporins, closure of the unit to new admissions, and strict cohorting of colonised infants resulted in a prompt end to the outbreak. This outbreak suggests that the routine use of third generation cephalosporins for suspected sepsis may be inappropriate in the presence of a large reservoir of organisms with the potential for rapidly developing resistance. Routine bacteriological surveillance, however, might permit their use on a rotational basis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3827292      PMCID: PMC1778254          DOI: 10.1136/adc.62.2.148

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

Review 1.  Microbial resistance to newer generation beta-lactam antibiotics: clinical and laboratory implications.

Authors:  C C Sanders; W E Sanders
Journal:  J Infect Dis       Date:  1985-03       Impact factor: 5.226

Review 2.  The beta-lactamases of gram-negative bacteria and their possible physiological role.

Authors:  M H Richmond; R B Sykes
Journal:  Adv Microb Physiol       Date:  1973       Impact factor: 3.517

3.  Development of resistance to beta-lactam antibiotics with special reference to third-generation cephalosporins.

Authors:  E Collatz; L Gutmann; R Williamson; J F Acar
Journal:  J Antimicrob Chemother       Date:  1984-09       Impact factor: 5.790

Review 4.  Emergence of resistance during therapy with the newer beta-lactam antibiotics: role of inducible beta-lactamases and implications for the future.

Authors:  C C Sanders; W E Sanders
Journal:  Rev Infect Dis       Date:  1983 Jul-Aug

5.  Klebsiella infection in a neonatal intensive care unit: role of bacteriological surveillance.

Authors:  M E Morgan; C A Hart; R W Cooke
Journal:  J Hosp Infect       Date:  1984-12       Impact factor: 3.926

6.  An outbreak of gentamicin-resistant Enterobacter cloacae infections in a pediatric intensive care unit.

Authors:  E L Anderson; J P Hieber
Journal:  Infect Control       Date:  1983 May-Jun

7.  Reduced sensitivity to beta-lactam antibiotics arising during ceftazidime treatment of Pseudomonas aeruginosa infections.

Authors:  A King; K Shannon; S Eykyn; I Phillips
Journal:  J Antimicrob Chemother       Date:  1983-10       Impact factor: 5.790

8.  Gentamicin vs cefotaxime for therapy of neonatal sepsis. Relationship to drug resistance.

Authors:  C S Bryan; J F John; M S Pai; T L Austin
Journal:  Am J Dis Child       Date:  1985-11

9.  Clinical efficacy of cefotaxime in serious infections.

Authors:  P H Karakusis; J M Feczko; L J Goodman; D M Hanlon; A A Harris; S Levin; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1982-01       Impact factor: 5.191

10.  Chromosomal beta-lactamases of Enterobacter cloacae are responsible for resistance to third-generation cephalosporins.

Authors:  A H Seeberg; R M Tolxdorff-Neutzling; B Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

  10 in total
  23 in total

1.  Rationing antibiotic use in neonatal units.

Authors:  D Isaacs
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-01       Impact factor: 5.747

Review 2.  All great truths are iconoclastic: selective decontamination of the digestive tract moves from heresy to level 1 truth.

Authors:  Hendrick K F van Saene; Andy J Petros; Graham Ramsay; Derrick Baxby
Journal:  Intensive Care Med       Date:  2003-04-10       Impact factor: 17.440

3.  Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome.

Authors:  S Raziuddin; M E Elawad
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

4.  Antibiotic therapy in neonatal and pediatric septic shock.

Authors:  Rajesh K Aneja; Ruby Varughese-Aneja; Carol G Vetterly; Joseph A Carcillo
Journal:  Curr Infect Dis Rep       Date:  2011-10       Impact factor: 3.725

Review 5.  Enterobacter spp.: pathogens poised to flourish at the turn of the century.

Authors:  W E Sanders; C C Sanders
Journal:  Clin Microbiol Rev       Date:  1997-04       Impact factor: 26.132

6.  Arbitrarily primed PCR, ribotyping, and plasmid pattern analysis applied to investigation of a nosocomial outbreak due to Enterobacter cloacae in a neonatal intensive care unit.

Authors:  F Grattard; B Pozzetto; P Berthelot; I Rayet; A Ros; B Lauras; O G Gaudin
Journal:  J Clin Microbiol       Date:  1994-03       Impact factor: 5.948

7.  Choice of antibiotics in late neonatal sepsis in the extremely low birth weight infant.

Authors:  Tara R Allen; Orlando P da Silva
Journal:  Can J Infect Dis       Date:  2003-01

8.  The use of the PhP-KE biochemical fingerprinting system in epidemiological studies of faecal Enterobacter cloacae strains from infants in Swedish neonatal wards.

Authors:  I Kühn; K Tullus; L G Burman
Journal:  Epidemiol Infect       Date:  1991-10       Impact factor: 2.451

9.  Epidemiological fingerprinting of Enterobacter cloacae by small-fragment restriction endonuclease analysis and pulsed-field gel electrophoresis of genomic restriction fragments.

Authors:  R Haertl; G Bandlow
Journal:  J Clin Microbiol       Date:  1993-01       Impact factor: 5.948

10.  Enterobacteriaceae and neonatal necrotising enterocolitis.

Authors:  M R Millar; P MacKay; M Levene; V Langdale; C Martin
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.